These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Fibroblast growth factor and transforming growth factor beta repress transcription of the myogenic regulatory gene MyoD1. Vaidya TB; Rhodes SJ; Taparowsky EJ; Konieczny SF Mol Cell Biol; 1989 Aug; 9(8):3576-9. PubMed ID: 2797000 [TBL] [Abstract][Full Text] [Related]
46. Effect of cellular determination on oncogenic transformation by chemicals and oncogenes. Harrington MA; Gonzales F; Jones PA Mol Cell Biol; 1988 Oct; 8(10):4322-7. PubMed ID: 2460742 [TBL] [Abstract][Full Text] [Related]
47. Overexpression of DNA methyltransferase in myoblast cells accelerates myotube formation. Takagi H; Tajima S; Asano A Eur J Biochem; 1995 Jul; 231(2):282-91. PubMed ID: 7635139 [TBL] [Abstract][Full Text] [Related]
48. Atypical protein kinase Cs are the Ras effectors that mediate repression of myogenic satellite cell differentiation. Fedorov YV; Jones NC; Olwin BB Mol Cell Biol; 2002 Feb; 22(4):1140-9. PubMed ID: 11809805 [TBL] [Abstract][Full Text] [Related]
49. MicroRNA-214 promotes myogenic differentiation by facilitating exit from mitosis via down-regulation of proto-oncogene N-ras. Liu J; Luo XJ; Xiong AW; Zhang ZD; Yue S; Zhu MS; Cheng SY J Biol Chem; 2010 Aug; 285(34):26599-607. PubMed ID: 20534588 [TBL] [Abstract][Full Text] [Related]
50. Kras activation in p53-deficient myoblasts results in high-grade sarcoma formation with impaired myogenic differentiation. McKinnon T; Venier R; Dickson BC; Kabaroff L; Alkema M; Chen L; Shern JF; Yohe ME; Khan J; Gladdy RA Oncotarget; 2015 Jun; 6(16):14220-32. PubMed ID: 25992772 [TBL] [Abstract][Full Text] [Related]
51. Effect of myogenic determination on tumorigenicity of chemically transformed 10T1/2 cells. Hustad CM; Jones PA Mol Carcinog; 1991; 4(2):153-61. PubMed ID: 1710465 [TBL] [Abstract][Full Text] [Related]
52. An activated c-Ha-ras allele blocks the induction of muscle-specific genes whose expression is contingent on mitogen withdrawal. Payne PA; Olson EN; Hsiau P; Roberts R; Perryman MB; Schneider MD Proc Natl Acad Sci U S A; 1987 Dec; 84(24):8956-60. PubMed ID: 3122209 [TBL] [Abstract][Full Text] [Related]
53. Control of myogenic differentiation by cellular oncogenes. Schneider MD; Olson EN Mol Neurobiol; 1988; 2(1):1-39. PubMed ID: 3077064 [TBL] [Abstract][Full Text] [Related]
54. Analysis of myogenesis by somatic cell hybridization. I. Myogenic competence of homotypic hybrids derived from rat L6 myoblasts. Lawrence JB; Konieczny SF; Shaffer M; Coleman AW; Coleman JR Exp Cell Res; 1982 Dec; 142(2):261-72. PubMed ID: 7173324 [No Abstract] [Full Text] [Related]
55. Neudesin Neurotrophic Factor Promotes Bovine Preadipocyte Differentiation and Inhibits Myoblast Myogenesis. Su X; Wang Y; Li A; Zan L; Wang H Animals (Basel); 2019 Dec; 9(12):. PubMed ID: 31835509 [TBL] [Abstract][Full Text] [Related]
56. Differential signaling through NFkappaB does not ameliorate skeletal myoblast apoptosis during differentiation. Dee K; DeChant A; Weyman CM FEBS Lett; 2003 Jun; 545(2-3):246-52. PubMed ID: 12804784 [TBL] [Abstract][Full Text] [Related]
57. Aberrant expression of high mobility group chromosomal protein 14 affects cellular differentiation. Pash JM; Alfonso PJ; Bustin M J Biol Chem; 1993 Jun; 268(18):13632-8. PubMed ID: 8514795 [TBL] [Abstract][Full Text] [Related]
58. Increased prostaglandin H synthase-1 expression and activity level in stably Harvey-ras transfected C3H10T1/2 cells. Xu X; Burgess JR; Teegarden D Cancer Lett; 1997 Oct; 119(1):87-92. PubMed ID: 18372526 [TBL] [Abstract][Full Text] [Related]